Stay updated on Inotuzumab Ozogamicin in ALL Clinical Trial

Sign up to get notified when there's something new on the Inotuzumab Ozogamicin in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inotuzumab Ozogamicin in ALL Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T14:45:26.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    0.8%
    Check dated 2026-10-25T13:41:09.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:03:24.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T13:55:42.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study's record history now includes a new revision label v3.7.0. The older revision label v3.6.6 was removed, updating the visible history trail.
    Difference
    0.1%
    Check dated 2026-09-20T14:25:00.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.6, is added to the version history, and the previous Revision: v3.6.5 is removed. This signals a platform update rather than changes to the study record itself.
    Difference
    0.1%
    Check dated 2026-08-29T23:35:03.000Z thumbnail image

Stay in the know with updates to Inotuzumab Ozogamicin in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin in ALL Clinical Trial page.